Ruojun Qiu

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 10

Top Topics

Top Venues

Hepatology communications

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Journal of molecular endocrinology

This page only lists publications with an associated author ORCID identifier.

Publications

Ruojun Qiu, Shuo Wang, Dingyi Lin, Yingzi He, Shaohan Huang, Beibei Wu, Hong Li, Min Wang, Fenping Zheng
Mice harboring a R133L heterozygous mutation in LMNA exhibited ectopic lipid accumulation, aging, and mitochondrial dysfunction in adipose tissue. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 37 (2) (2023)
Ruojun Qiu, Shuo Wang, Dingyi Lin, Yingzi He, Shaohan Huang, Beibei Wu, Hong Li, Min Wang, Fenping Zheng
Mice harboring a R133L heterozygous mutation in LMNA exhibited ectopic lipid accumulation, aging, and mitochondrial dysfunction in adipose tissue. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 37 (2) (2023)
Shaohan Huang, Beibei Wu, Yingzi He, Ruojun Qiu, Tian Yang, Shuo Wang, Yongzhen Lei, Hong Li, Fenping Zheng
Canagliflozin ameliorates the development of NAFLD by preventing NLRP3-mediated pyroptosis through FGF21-ERK1/2 pathway. Hepatology communications 7 (3) (2023)
Shaohan Huang, Beibei Wu, Yingzi He, Ruojun Qiu, Tian Yang, Shuo Wang, Yongzhen Lei, Hong Li, Fenping Zheng
Canagliflozin ameliorates the development of NAFLD by preventing NLRP3-mediated pyroptosis through FGF21-ERK1/2 pathway. Hepatology communications 7 (3) (2023)
Shaohan Huang, Beibei Wu, Yingzi He, Ruojun Qiu, Tian Yang, Shuo Wang, Yongzhen Lei, Hong Li, Fenping Zheng
Canagliflozin ameliorates the development of NAFLD by preventing NLRP3-mediated pyroptosis through FGF21-ERK1/2 pathway. Hepatology communications 7 (3) (2023)
Beibei Wu, Ruojun Qiu, Shuo Wang, Yingzi He, Jing Wang, Zhiye Xu, Xihua Lin, Hong Li, Fenping Zheng
Transthyretin knockdown recapitulates the insulin-sensitizing effects of exercise and promotes skeletal muscle adaptation to exercise endurance. Journal of molecular endocrinology 71 (1) (2023)
Ruojun Qiu, Shuo Wang, Dingyi Lin, Yingzi He, Shaohan Huang, Beibei Wu, Hong Li, Min Wang, Fenping Zheng
Mice harboring a R133L heterozygous mutation in LMNA exhibited ectopic lipid accumulation, aging, and mitochondrial dysfunction in adipose tissue. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 37 (2) (2023)
Shaohan Huang, Beibei Wu, Yingzi He, Ruojun Qiu, Tian Yang, Shuo Wang, Yongzhen Lei, Hong Li, Fenping Zheng
Canagliflozin ameliorates the development of NAFLD by preventing NLRP3-mediated pyroptosis through FGF21-ERK1/2 pathway. Hepatology communications 7 (3) (2023)
Ruojun Qiu, Shuo Wang, Dingyi Lin, Yingzi He, Shaohan Huang, Beibei Wu, Hong Li, Min Wang, Fenping Zheng
Mice harboring a R133L heterozygous mutation in LMNA exhibited ectopic lipid accumulation, aging, and mitochondrial dysfunction in adipose tissue. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 37 (2) (2023)
Shaohan Huang, Beibei Wu, Yingzi He, Ruojun Qiu, Tian Yang, Shuo Wang, Yongzhen Lei, Hong Li, Fenping Zheng
Canagliflozin ameliorates the development of NAFLD by preventing NLRP3-mediated pyroptosis through FGF21-ERK1/2 pathway. Hepatology communications 7 (3) (2023)